The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers

Εμφάνιση άλλων εκδόσεων (1)

Proteomics can help to discover and quantify novel biomarkers and we show how this is achieved using liver fibrosis as an example.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Gangadharan, B, Kumar, A, Barnes, E, Klenerman, P, Dwek, R, Zitzmann, N
Μορφή:	Conference item
Έκδοση:	Wiley 2016

Παρόμοια τεκμήρια

The Use of Proteomics in Diagnostics: Liver Fibrosis Biomarkers
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2016)

PTH-092 Discovery and quantitation of novel liver fibrosis biomarkers using proteomics
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2015)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients using proteomics
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2014)

New proteomics approaches for discovering biomarkers: Searching for liver fibrosis markers in hepatitis c patients
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2012)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2016)

New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2014)

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2007)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2011)

New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2011)

Discovery of new liver fibrosis markers in hepatitis C patients using proteomics
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2011)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2012)

Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2012)

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2008)

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2010)

LC-MS based discovery of novel protein biomarkers and their quantitation in HCV fibrosis and NASH diseased human serum
ανά: Kumar, A, κ.ά.
Έκδοση: (2014)

Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study.
ανά: Bevin Gangadharan, κ.ά.
Έκδοση: (2012-01-01)

Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery.
ανά: Pardo, M, κ.ά.
Έκδοση: (2007)

Towards the first antibody-free serum biomarker assay for NAFLD
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2017)

Discovery and quantitation of novel liver fibrosis biomarkers in hepatitis C patients
ανά: Gangadharan, B
Έκδοση: (2017)

Towards the first antibody-free serum biomarker assay for NAFLD
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2017)

Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.
ανά: Narayan, R, κ.ά.
Έκδοση: (2009)

Applying proteomics technology to platelet research.
ανά: García, A, κ.ά.
Έκδοση: (2005)

Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro.
ανά: Woodhouse, S, κ.ά.
Έκδοση: (2010)

SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
ανά: Yi Luo, κ.ά.
Έκδοση: (2021-05-01)

Two dimensional gel electrophoresis using narrow pH 3-5.6 immobilised pH gradient strips identifies potential novel disease biomarkers in plasma or serum
ανά: Gangadharan, B, κ.ά.
Έκδοση: (2011)

Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
ανά: Bharucha, T, κ.ά.
Έκδοση: (2019)

Differential proteome analysis of CRP-activated platelets
ανά: Garcia, A, κ.ά.
Έκδοση: (2005)

Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example
ανά: Kumar, A, κ.ά.
Έκδοση: (2017)

Diagnostics of Fibrosis in Alcoholic Liver Damage
ανά: E. N. Travenko, κ.ά.
Έκδοση: (2019-09-01)

Non-invasive Diagnostics of Liver Fibrosis
ανά: Mihaylov R., κ.ά.
Έκδοση: (2017-05-01)

Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.
ανά: Antrobus, R, κ.ά.
Έκδοση: (2009)

Use of iminosugar derivatives to inhibit ion channel activity
ανά: Zitzmann, N, κ.ά.
Έκδοση: (2004)

Serum biomarkers for liver fibrosis assessment
ανά: Maroto-García Julia, κ.ά.
Έκδοση: (2023-11-01)

Proteome analysis of human uveal melanoma cells by two-dimensional gel electrophoresis and mass spectrometry
ανά: Pardo, M, κ.ά.
Έκδοση: (2005)

Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
ανά: Pardo, M, κ.ά.
Έκδοση: (2005)

Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children
ανά: Yasser E Nassef, κ.ά.
Έκδοση: (2013-11-01)

Salivary biomarkers and proteomics: future diagnostic and clinical utilities
ανά: M. Castagnola, κ.ά.
Έκδοση: (2017-04-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
ανά: E V Vinnitskaia, κ.ά.
Έκδοση: (2013-02-01)

Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry
ανά: García, A, κ.ά.
Έκδοση: (2004)

Multiple reaction monitoring and multiple reaction monitoring cubed based assay for the quantitation of apolipoprotein F
ανά: Kumar, A, κ.ά.
Έκδοση: (2016)